Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms

• Brigit E. Riley ,

  Contributed equally to this work with: Brigit E. Riley, Shyra J. Gardai

  * E-mail: brigitriley@gmail.com (BER); sgardai@gmail.com (SJG)

  Affiliation Elan Pharmaceuticals, South San Francisco, California, United States of America

  ⨯
• Shyra J. Gardai ,

  Contributed equally to this work with: Brigit E. Riley, Shyra J. Gardai

  * E-mail: brigitriley@gmail.com (BER); sgardai@gmail.com (SJG)

  Affiliation Elan Pharmaceuticals, South San Francisco, California, United States of America

  ⨯
• Dorothea Emig-Agius,

  Affiliation Thomson Reuters, Carlsbad, California, United States of America

  ⨯
• Marina Bessarabova,

  Affiliation Thomson Reuters, Carlsbad, California, United States of America

  ⨯
• Alexander E. Ivliev,

  Affiliation Thomson Reuters, Carlsbad, California, United States of America

  ⨯
• Birgit Schüle,

  Affiliation The Parkinson's Institute, Sunnyvale, California, United States of America

  ⨯
• Jeff Alexander,

  Affiliation Elan Pharmaceuticals, South San Francisco, California, United States of America

  ⨯
• William Wallace,

  Affiliation Elan Pharmaceuticals, South San Francisco, California, United States of America

  ⨯
• Glenda M. Halliday,

  Affiliation Neuroscience Research Australia and the University of New South Wales, Sydney, N.S.W., Australia

  ⨯
• J. William Langston,

  Affiliation The Parkinson's Institute, Sunnyvale, California, United States of America

  ⨯
• Scott Braxton,

  Affiliation Thomson Reuters, Carlsbad, California, United States of America

  ⨯
• Ted Yednock,

  Affiliation Elan Pharmaceuticals, South San Francisco, California, United States of America

  ⨯
• Thomas Shaler,

  Affiliation SRI International, Menlo Park, California, United States of America

  ⨯
• Jennifer A. Johnston

  Affiliation Elan Pharmaceuticals, South San Francisco, California, United States of America

  ⨯